Live from the NIH registry
Studies recruiting near Lakeland right now
Top 25 of 200 recruiting studies, sorted by proximity — each links to its official registry page
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Winter Haven Hospital — Winter Haven, Florida (13.7 mi)
· Sponsor: NRG Oncology
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
FL Medical Clinic Orlando Health — Zephyrhills, Florida (18.5 mi)
· Sponsor: Novartis Pharmaceuticals
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma
Phase 1, Phase 2
Interventional 768 participants sought
Helios CR Inc — Lakeland, Florida (1.2 mi)
· Sponsor: Boehringer Ingelheim
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Lakeland, Florida (1.2 mi)
· Sponsor: AstraZeneca
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Winter Haven Hospital — Winter Haven, Florida (13.7 mi)
· Sponsor: Novo Nordisk A/S
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50239 — Brandon, Florida (21.8 mi)
· Sponsor: UCB Biopharma SRL
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
Radiology and Imaging Specialists — Lakeland, Florida (1.2 mi)
· Sponsor: Penumbra Inc.
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (26.1 mi)
· Sponsor: SWOG Cancer Research Network
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Clinical Research of Central Florida — Lakeland, Florida (1.2 mi)
· Sponsor: Amgen
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Clinical Research of Center Florida — Lakeland, Florida (1.2 mi)
· Sponsor: Crystalys Therapeutics
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
The Oncology Institute — Lakeland, Florida (1.2 mi)
· Sponsor: Jazz Pharmaceuticals
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Depressive Disorder, Major
Phase 3
Interventional 752 participants sought
Clinical Research of Brandon — Brandon, Florida (21.8 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Bay Area Cardiology — Brandon, Florida (21.8 mi)
· Sponsor: Boehringer Ingelheim
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
Phase 1, Phase 2
Interventional 37 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (26.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 2
Interventional 164 participants sought
EquiPath Health and Research Tampa Bay, LLC — Riverview, Florida (26.2 mi)
· Sponsor: Syndeio Biosciences, Inc
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 2, Phase 3
Interventional 576 participants sought
Florida Retina Consultants - Lakeland /ID# 275012 — Lakeland, Florida (1.2 mi)
· Sponsor: AbbVie
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Bay Area Cardiology — Brandon, Florida (21.8 mi)
· Sponsor: Boehringer Ingelheim
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (26.1 mi)
· Sponsor: NRG Oncology
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Florida Retina Consultants — Lakeland, Florida (1.2 mi)
· Sponsor: EyeBiotech Ltd.
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists North / Sarah Cannon Research Institute — Brandon, Florida (21.8 mi)
· Sponsor: American Society of Clinical Oncology
Lay-Delivered Behavioral Activation in Senior Centers
Depression
N/A
Interventional 288 participants sought
Brandon Senior Center — Brandon, Florida (21.8 mi)
· Sponsor: University of Washington
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Brandon, Florida (21.8 mi)
· Sponsor: GlaxoSmithKline
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Lakeland, Florida (1.2 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — Riverview, Florida (26.2 mi)
· Sponsor: AstraZeneca
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
Attention Deficit Disorder With Hyperactivity (ADHD)
Phase 2
Interventional 312 participants sought
Alkermes Investigational Site — Lakeland, Florida (1.2 mi)
· Sponsor: Alkermes, Inc.